About Open Orphan
Open Orphan is a company based in London (United Kingdom) founded in 2017. The company has 218 employees as of January 31, 2021. Open Orphan has completed 1 acquisition, including CHIMagents. Open Orphan offers products and services including Human Challenge Trials and Laboratory Services. Open Orphan operates in a competitive market with competitors including Altasciences, Ask Gene Pharma, Celerion, MindBio Therapeutics and iCardiac Technologies, among others.
- Headquarter London, United Kingdom
- Employees 218 as on 31 Jan, 2021
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Open Orphan Plc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$14.66 M (USD), Post-IPO
May 22, 2020
-
Investors
Not available
-
Employee Count
218
as on Jan 31, 2021
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Open Orphan
Open Orphan offers a comprehensive portfolio of products and services, including Human Challenge Trials and Laboratory Services.
Conducts controlled trials for testing vaccines against infectious diseases.
Provides analytical support for clinical research and drug development.
Funding Insights of Open Orphan
Investments & Acquisitions by Open Orphan
Open Orphan has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CHIMagents.
Investment portfolio details for Open Orphan
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Potential antiviral drugs and vaccines are manufactured for testing.
|
Locked | Locked | 2019 | Locked |
Complete acquisition details for Open Orphan
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Open Orphan
Detailed financials for Open Orphan
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Open Orphan Comparisons
Peer comparison for Open Orphan
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Open Orphan
Open Orphan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Altasciences, Ask Gene Pharma, Celerion, MindBio Therapeutics and iCardiac Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Early phase clinical research services are provided in North America.
|
|
| Locked | Locked | Locked |
Biosimilars and biosuperiors are developed and commercialized in biotechnology.
|
|
| Locked | Locked | Locked |
Early clinical research services are provided for drug development.
|
|
| Locked | Locked | Locked |
Provider of phase I & II clinical trial services for mental health diseases
|
|
| Locked | Locked | Locked |
Cardiac safety testing and respiratory laboratory services are provided.
|
|
| Locked | Locked | Locked |
Clinical development services are provided to pharmaceutical clients worldwide.
|
Detailed competitors of Open Orphan
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Open Orphan
Complete news archive for Open Orphan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Open Orphan
Open Orphan was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Open Orphan is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
As of Jan 31, 2021, the latest employee count at Open Orphan is 218.
Open Orphan was founded in 2017 and is headquartered in London, United Kingdom. Operations focus on the pharmaceutical sector, where vaccines and antivirals are tested through controlled human challenge studies and clinical trials. Services extend to infectious and respiratory disease research, as well as laboratory support. Contract research organization functions are handled for pharmaceutical clients, supporting drug development processes.
Open Orphan's top competitors include Celerion, Ask Gene Pharma and Altasciences.
Open Orphan offers Human Challenge Trials and Laboratory Services.
Open Orphan has made 1 acquisition, including CHIMagents.